Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomoncytic leukaemia and acute myeloid leaukaemia

Richard Edlin, M Connock, S Tubeuf, Jeff Round, A Fry-Smith, C Hyde, Greenheld, W

Research output: Contribution to journalArticle (Academic Journal)

Original languageEnglish
Pages (from-to)69-74
Number of pages6
JournalHealth Technology Assessment
Volume14
Publication statusPublished - 2010

Cite this

Edlin, R., Connock, M., Tubeuf, S., Round, J., Fry-Smith, A., Hyde, C., & W, G. (2010). Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomoncytic leukaemia and acute myeloid leaukaemia. Health Technology Assessment, 14, 69-74.